Literature DB >> 32333338

Optical coherence tomography angiography findings in systemic lupus erythematosus patients with no ocular disease.

Francesco Pichi1,2, Elizabeth Woodstock3, Steven Hay3, Piergiorgio Neri3,4.   

Abstract

PURPOSE: Retinal manifestations are present in 10% of patients with systemic lupus erythematosus (SLE) and consist of vascular changes that can be sight-threatening. Optical coherence tomography angiography (OCTA) is a novel imaging modality that detects movement inside the blood vessels without dye injection and transforms this movement into an angiographic map. The aim of this study is to describe subclinical vessels changes in the eyes of patients with SLE but no retinal manifestations.
METHODS: In this cross-sectional study, 15 patients with SLE but no clinical ophthalmic manifestations were scanned through OCTA of the iris and at the level of the macula. Qualitative aspects of the iris vessels, and measure of the foveal avascular zone (FAZ) and vessel density were compared to a cohort of 15 normal controls.
RESULTS: Patients with SLE, even in the absence of ophthalmic manifestations, present a qualitative increase in the iris vessels flow, and enlargement of the FAZ (0.22 ± 0.12 mm2) and a decrease in the vascular density (11.221 ± 1.933 mm-1) of the superficial capillary plexus on OCTA that cannot be highlighted clinically. DISCUSSION: OCTA can be used in a noninvasive way to detect subclinical vascular changes in patients with SLE. How this information will influence the follow-up and management of these cases will require further prospective studies with a collaborative effort between ophthalmologists and rheumatologists.

Entities:  

Keywords:  Iris vessels; Optical coherence tomography angiography; Retinal vessels; Systemic lupus erythematosus

Mesh:

Year:  2020        PMID: 32333338     DOI: 10.1007/s10792-020-01388-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

Review 1.  Use of optical coherence tomography angiography in the uveitis clinic.

Authors:  Francesco Pichi; Steven Hay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-16       Impact factor: 3.535

2.  Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.

Authors:  Sevgi Subasi; Kubra Demirci Kucuk; Senar San; Ayse Cefle; Ecem Onder Tokuc; Sibel Balci; Ayten Yazici
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-06       Impact factor: 3.535

Review 3.  Imaging of iris vasculature: current limitations and future perspective.

Authors:  Claudio Iovino; Enrico Peiretti; Mirco Braghiroli; Filippo Tatti; Abhilasha Aloney; Michele Lanza; Jay Chhablani
Journal:  Eye (Lond)       Date:  2021-10-14       Impact factor: 4.456

4.  Evaluation of subclinical ocular involvement in patients with deficiency of adenosine deaminase 2 (DADA2).

Authors:  Tuğba Kurumoğlu İncekalan; Rabia Miray Kışla Ekinci; Göksu Hande Naz Şimdivar; Neşe Çetin Doğan; Emine Çiloğlu
Journal:  Clin Rheumatol       Date:  2022-05-05       Impact factor: 3.650

5.  Retinal Vascular Assessment in Psoriasis: A Multicenter Study.

Authors:  Niccolò Castellino; Antonio Longo; Matteo Fallico; Andrea Russo; Vincenza Bonfiglio; Gilda Cennamo; Federica Fossataro; Gabriella Fabbrocini; Anna Balato; Guglielmo Parisi; Rosa Maria D'urso; Francesco Lacarrubba; Maria Letizia Musumeci; Pietro Alosi; Francesco Petrillo; Giuseppe Micali; Teresio Avitabile; Michele Reibaldi
Journal:  Front Neurosci       Date:  2021-01-25       Impact factor: 4.677

6.  Retinal Microvasculature and Conjunctival Vessel Alterations in Patients With Systemic Lupus Erythematosus-An Optical Coherence Tomography Angiography Study.

Authors:  Wen-Qing Shi; Ting Han; Ren Liu; Qiang Xia; Tian Xu; Yan Wang; Shuang Cai; Shui-Lin Luo; Yi Shao; Rui Wu
Journal:  Front Med (Lausanne)       Date:  2021-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.